Supernus Pharmaceuticals (SUPN) EPS (2012 - 2026)
Supernus Pharmaceuticals (SUPN) EPS from Jun 30, 2012 to Mar 31, 2026. The TTM Supernus Pharmaceuticals (SUPN) EPS is -$0.50. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Supernus Pharmaceuticals (SUPN) EPS CAGR table
| Period | CAGR |
|---|---|
| All Time TTM | -11.79% |
Annual EPS change of Supernus Pharmaceuticals (SUPN)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.04 | -94.12% |
| 2025 | -$0.67 | -150.64% |
| 2024 | $1.33 | +5393.09% |
| 2023 | $0.02 | -97.88% |
| 2022 | $1.14 | +13.65% |
| 2021 | $1 | -58.23% |
| 2020 | $2.40 | +11.57% |
| 2019 | $2.15 | +1.44% |
| 2018 | $2.12 | +90.06% |
| 2017 | $1.12 | -38.85% |
| 2016 | $1.83 | +541.72% |
| 2015 | $0.28 | -211.95% |
| 2014 | -$0.25 | -63.89% |
| 2013 | -$0.70 | -49.79% |
| 2012 | -$1.40 | N/A |